To include your compound in the COVID-19 Resource Center, submit it here.
Aisling Capital announced the closing of Aisling Capital IV at $280 million on Thursday.
Managing Partner Steve Elms
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury